欢迎来到天天文库
浏览记录
ID:52936633
大小:185.18 KB
页数:2页
时间:2020-04-02
《超声电导仪治疗颈部淋巴结结核的临床观察.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、医械临床IClinicalMedicalEauiDment·71·超声电导仪治疗颈部淋巴结结核的临床观察陈志,梁建琴,王金河,冯士生,丁娜,杨海英[摘要]目的:观察超声电导仪治疗颈部淋巴结结核的临床疗效和安全性。方法:将48例颈部淋巴结结核患者随机分为治疗组和对照组.每组各24例,2纽均以常规抗结核化疗方案为基础,治疗组加用超声电导仪经皮导入异烟肼注射液、硫酸阿米卡星注射液,对照组加用局部注射异烟肼注射液、硫酸阿米卡星注射液,并追踪观察治疗结果和并发症。结果:以患者治疗后的主要症状、体征缓解情况,局部超声捡查等为疗效判断依据,评价治疗结果:治疗组经2个疗程
2、治疗后好转率明显高于对照组(P3、n—he,FENGShi—sheng,DINGNa,YANGHai—ying(InstituteofTuberculosis,the309thHospitalofthePLA,Beijing100091,China)AbstractObjectiveToobselweeficacyandsafetyoftreatmentf0rcervicallymphoidtuberculosisbyeleetrophonophoresis(EPP).Methods48patientswithcervicallymphoidtuberculosiswererandomly4、dividedintotreatmentgroupandcontrolgroup,eachgrouphas24ones.Onthebasisofantitubereulosischemotherapy,thepatientsfronttreatmentgroupweretreatedbyEPPtotransfuseisoniazidandanfikacinsulfatethroughtransdermal,andthecontrolgroupwastreatedbylocaliniectionofisoniazidandamikacinsulfate.Th5、eneffieacyandcomplicationsaftertreatmentwerefollowedup.R咖】tBEficacywasassessedaccordingtosymptoms,physicalsignsandlocalultrasoundaftertreatment.Aftertwo—coursetreatment.thetreatmentgrouphadhigherimprovementratethanthecontrolgroup<0.05).Seriousadversereactionsandcomplicationshadnot6、befoundinallthepatients.ConclusionTreatmentwithelectr0phonophoresiscanincreaseimprovementrateofcervicallymphoidtuberculosis.Moreover,itdoesnthaveseriousadversereactionsandcomplicationsan(1isaneft)ctiveandsafemethodfortrealmentofcervica1lymphoidtuberculosis.『ChineseMedicaIEquipment7、dournaI,2011,32(3):71—721Keywordseleetrophonophoresis;lymphoidtuberculosis;clinical1一般资料导人药物:异炯肼注射液0.1g/支,批弓:090319,天津药观察对象来自于2009一O7—2Ol0—02期间我科住院患业集团新郑股份有限公司。者。所有观察范围内患者均经症状、体征、PPD试验、颈部淋巴硫酸阿米卡星注射液0-2g/支,批号:090501,上海旭东海结超、颈部CT、颈部淋巴结针吸活检等,明确诊断为淋巴结普药业有限公司。结核,确诊诊断标准参照《现代结核病学》中淋巴结结核相8、关3治疗方法章节⋯、将患者随机分为治疗组和对照组各24例。在治疗组
3、n—he,FENGShi—sheng,DINGNa,YANGHai—ying(InstituteofTuberculosis,the309thHospitalofthePLA,Beijing100091,China)AbstractObjectiveToobselweeficacyandsafetyoftreatmentf0rcervicallymphoidtuberculosisbyeleetrophonophoresis(EPP).Methods48patientswithcervicallymphoidtuberculosiswererandomly
4、dividedintotreatmentgroupandcontrolgroup,eachgrouphas24ones.Onthebasisofantitubereulosischemotherapy,thepatientsfronttreatmentgroupweretreatedbyEPPtotransfuseisoniazidandanfikacinsulfatethroughtransdermal,andthecontrolgroupwastreatedbylocaliniectionofisoniazidandamikacinsulfate.Th
5、eneffieacyandcomplicationsaftertreatmentwerefollowedup.R咖】tBEficacywasassessedaccordingtosymptoms,physicalsignsandlocalultrasoundaftertreatment.Aftertwo—coursetreatment.thetreatmentgrouphadhigherimprovementratethanthecontrolgroup<0.05).Seriousadversereactionsandcomplicationshadnot
6、befoundinallthepatients.ConclusionTreatmentwithelectr0phonophoresiscanincreaseimprovementrateofcervicallymphoidtuberculosis.Moreover,itdoesnthaveseriousadversereactionsandcomplicationsan(1isaneft)ctiveandsafemethodfortrealmentofcervica1lymphoidtuberculosis.『ChineseMedicaIEquipment
7、dournaI,2011,32(3):71—721Keywordseleetrophonophoresis;lymphoidtuberculosis;clinical1一般资料导人药物:异炯肼注射液0.1g/支,批弓:090319,天津药观察对象来自于2009一O7—2Ol0—02期间我科住院患业集团新郑股份有限公司。者。所有观察范围内患者均经症状、体征、PPD试验、颈部淋巴硫酸阿米卡星注射液0-2g/支,批号:090501,上海旭东海结超、颈部CT、颈部淋巴结针吸活检等,明确诊断为淋巴结普药业有限公司。结核,确诊诊断标准参照《现代结核病学》中淋巴结结核相
8、关3治疗方法章节⋯、将患者随机分为治疗组和对照组各24例。在治疗组
此文档下载收益归作者所有